CommonHealth lands vet to run patient, interactive

Share this article:
E-marketing veteran Meg Columbia-Walsh has joined WPP-held CommonHealth as managing partner and president.

In her new role, Columbia-Walsh assumes responsibility for CommonHealth's consumer, patient and interactive business, she told MM&M.

“The consumer industry has gone through a lot of change,” said Columbia-Walsh. “We went from being a healthcare-only

discipline to a direct-to-consumer discipline based on the packaged-goods model. Old tactics are not going to work. We really need to harness and build strategic insight into positioning that can be truly articulated into multiple channels. I think that is really the goal moving forward.”

Describing Columbia-Walsh as a force in the industry, CommonHealth CEO Matt Giegerich said, “We're absolutely convinced she will help drive CommonHealth's growth.”

In her 20-year career, Columbia-Walsh has served as managing director of healthcare and technology at Faith Popcorn's Brain Reserve; was partner/VP at Cap Gemini Ernst & Young; founded online healthcare advertising agency HealthTech Digital Communications; founded CBS Healthwatch; and was CEO of Oncology.com.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union